Skip to content

Clinical trials

Observational Carcinoma, Renal Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Observational Country / region: China Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20131
20182
20193
20211
20226
20235
202411
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Completed13
Unknown status8
Active, not recruiting5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital6
First Affiliated Hospital of Fujian Medical University3
Jinling Hospital, China3
Peking University First Hospital3
Peking University Third Hospital3
Tianjin Medical University Second Hospital3
Bayer2
Shao Pengfei2
AstraZeneca1
Beijing Friendship Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell44
Kidney Neoplasms12
Carcinoma3
Kidney Diseases2
Liver Neoplasms2
Lung Neoplasms2
Pancreatic Neoplasms2
Urogenital Neoplasms2
von Hippel-Lindau Disease2
Acute Kidney Injury1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.